These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25466525)

  • 1. Abdominal lipohypertrophy without insulin injection.
    Gungor K; Telci Caklili O; Oguz A
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):90. PubMed ID: 25466525
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.
    Vardar B; Kizilci S
    Diabetes Res Clin Pract; 2007 Aug; 77(2):231-6. PubMed ID: 17303282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.
    Hauner H; Stockamp B; Haastert B
    Exp Clin Endocrinol Diabetes; 1996; 104(2):106-10. PubMed ID: 8740933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010.
    Ji J; Lou Q
    Curr Med Res Opin; 2014 Jun; 30(6):1087-93. PubMed ID: 24552616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-induced lipohypertrophy: report of a case with histopathology.
    Fujikura J; Fujimoto M; Yasue S; Noguchi M; Masuzaki H; Hosoda K; Tachibana T; Sugihara H; Nakao K
    Endocr J; 2005 Oct; 52(5):623-8. PubMed ID: 16284443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes.
    Raile K; Noelle V; Landgraf R; Schwarz HP
    Exp Clin Endocrinol Diabetes; 2001; 109(8):393-6. PubMed ID: 11748486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of lipohypertrophy in diabetes care.
    Hambridge K
    Br J Nurs; 2007 May 10-23; 16(9):520-4. PubMed ID: 17551441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalised lipodystrophy and pregnancy.
    Sturley RH; Stirling C; Reckless JP
    Br J Obstet Gynaecol; 1994 Aug; 101(8):719-20. PubMed ID: 7947513
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin resistant diabetes showing anti-insulin receptor autoantibody with systemic scleroderma, acanthosis nigricans and total lipodystrophy (author's transl)].
    Sugawara H; Toyota T; Okuguchi F; Umezu M; Kai Y; Abe R; Maruhama Y; Goto Y; Hanew K; Utsumi N
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):361-9. PubMed ID: 7381285
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial lipodystrophy and insulin-resistant diabetes.
    Crome P; Keen H
    Diabete Metab; 1978 Jun; 4(2):81-4. PubMed ID: 680314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
    Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
    J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Images in clinical medicine. Insulin-induced lipohypertrophy.
    Landau S
    N Engl J Med; 2012 Feb; 366(5):e9. PubMed ID: 22296094
    [No Abstract]   [Full Text] [Related]  

  • 13. [Soft tumors in the mid abdomen and thighs. Diabetes, lipohypertrophy].
    Winter M
    MMW Fortschr Med; 2011 Oct; 153(43):5. PubMed ID: 22097618
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors].
    Dieleman JP; Hillebrand-Haverkort ME; van der Ende ME; Sturkenboom MC; Lange JM; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2856-60. PubMed ID: 10065260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin is a potent anti-diabetic in mice with lipodystrophy and insulin resistance.
    Berg JP
    Eur J Endocrinol; 2000 Feb; 142(2):114-6. PubMed ID: 10664517
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of abdominal fat distribution in noninsulin-dependent diabetes mellitus: relationship to insulin resistance.
    Gautier JF; Mourier A; de Kerviler E; Tarentola A; Bigard AX; Villette JM; Guezennec CY; Cathelineau G
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1306-11. PubMed ID: 9543160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipodystrophy and metabolic abnormalities in a case of adult dermatomyositis.
    Lee LA; Hobbs KF
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S85-7. PubMed ID: 17938031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with jet insulin injection in diabetes mellitus therapy: a clue to the pathogenesis of lipodystrophy.
    Cohn ML; Hingson RA; Narduzzi JV; Seddon JM
    Ala J Med Sci; 1974 Jul; 11(3):265-72. PubMed ID: 4451266
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease.
    Rooney DP; Ryan MF
    Diabet Med; 2006 Apr; 23(4):436-40. PubMed ID: 16620274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.